alzhub.org
Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Home › Research › Topics › dpp4-inhibitors

dpp4-inhibitors

3 studies tagged dpp4-inhibitors, dated 2017-07-27 to 2024-01-01. Bibliography: BibTeX (.bib) · RIS (.ris)

Newest in this topic

  1. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review 2024-01-01
  2. Possible role of DPP4 inhibitors to promote hippocampal neurogenesis in Alzheimer's disease 2018-03-02
  3. DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review 2017-07-27

Studies

3 studies carry this tag.

Date range

2017 to 2024

Top journals

  • American journal of Alzheimer's disease and other dementias 1
  • Current topics in medicinal chemistry 1
  • Journal of drug targeting 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. GLP-1/GIP Agonist as an Intriguing and Ultimate Remedy for Combating Alzheimer's Disease through its Supporting DPP4 Inhibitors: A Review

    ✓ Peer-reviewed alzhub usefulness score 41 out of 100. Current topics in medicinal chemistry 2024-01-01 Drug development

    With a focus on AD, the molecular and pharmacological effects of a few GLP-1/GIP analogs, both synthetic and natural, as well as DPP4 inhibitors, have been mentioned, which are in the preclinical and clinical studies.

  2. Possible role of DPP4 inhibitors to promote hippocampal neurogenesis in Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. Journal of drug targeting 2018-03-02 Drug development

    As well-known to the scientific community, Alzheimer's disease (AD) is an irreversible neurodegenerative disease that ends up with impairment of memory and cognition.

  3. DPP4 Inhibitors Can Be a Drug of Choice for Type 3 Diabetes: A Mini Review

    ✓ Peer-reviewed alzhub usefulness score 38 out of 100. American journal of Alzheimer's disease and other dementias 2017-07-27 Drug development

    As well known to the scientific community, Alzheimer's disease (AD) is an irreversible neurodegenerative disease that ends up with impairment of memory and cognition due to neuronal and synapse loss.

All topic tags with their study counts